Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: A gender difference

Growth Hormone and IGF Research

Volumn 14, Issue 6, 2004, Pages 436-441

  Soares, D V ^a,b   Conceicao F L ^a   Brasil, R R L O ^a   Spina, L D C ^a   Lobo, P M ^a   Silva, E M C ^a   Buescu, A ^a   Vaisman, M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Gender; GH deficiency; Growth hormone; Insulin like growth factor I

Indexed keywords

ANDROGEN; DESMOPRESSIN; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; GROWTH HORMONE; HUMAN GROWTH HORMONE; LEVOTHYROXINE; PREDNISONE; SOMATOMEDIN C; TESTOSTERONE ESTER;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOPHARYNGIOMA; CUSHING DISEASE; DYSGERMINOMA; EDEMA; FEMALE; GROWTH HORMONE DEFICIENCY; HISTIOCYTOSIS X; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MAINTENANCE DRUG DOSE; MALE; PINEAL BODY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEX DIFFERENCE; TITRIMETRY;

ADMINISTRATION, ORAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 14544277050     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.06.004     Document Type: Article

References (41)

1. R.C. Cuneo F. Salomon G.A. Magauley P.H. Sönksen The growth hormone deficiency syndrome in adults Clin. Endocrinol. 37 1992 387-397
2. F. Salomon R.C. Cuneo R. Hesp P.H. Sönksen The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency N. Engl. J. Med. 321 1989 1797-1803
3. S.J. Holmes G. Economou R.W. Whitehouse J.E. Adams S.M. Shalet Reduced bone mineral density in patients with adult onset growth hormone deficiency J. Clin. Endocrinol. Metab. 87 1994 669-674
4. J.O.L. Jørgensen S.A. Pedersen L. Thuesen et al. Beneficial effect of growth hormone treatment in GH-deficient adults Lancet 1 1989 1221-1225
5. T. Rosén L. Wiren L. Wilhelmsen I. Wiklund B.A. Bengtsson Decreased physiological well-being in adult patients with growth hormone deficiency Clin. Endocrinol. 40 1994 111-116
6. T. Rosén S. Edén G. Larson L. Wilhelmsen B.-Å. Bengtsson Cardiovascular risk factors in adult patients with growth hormone deficiency Acta Endocrinol. 129 1993 195-200
7. V. Markussis S.A. Beshyah C. Fisher P. Sharp N.A. Nicolaides D.G. Johnston Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults Lancet 340 1992 1188-1192
8. A. Rahim S.J. Holmes J.E. Adams S.M. Shalet Long-term change in the bone mineral density of adults with growth hormone (GH) deficiency in response to short or long-term GH replacement therapy Clin. Endocrinol. 48 1998 463-469
9. R.C. Cuneo F. Salomon G.F. Watts R. Hesp P.H. Sönksen Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency Metabolism 42 1993 1519-1523
10. A. Binnerts G.R. Swart J.H.P. Willsson et al. The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition Clin. Endocrinol. 37 1992 79-87
11. P.V. Carroll E.R. Christ B.-Å. Bengtsson et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee J. Clin. Endocrinol. Metab. 83 1998 382-385
12. G. Johannsson J.-O. Johansson in: B.-Å. Bengtsson J.P. Monson (Eds.) Growth Hormone Replacement in Adults: The First 5 Years of KIMS 2000 Oxford Pharma Genesis UK 115-132
13. J. Gibney J.D. Wallace T. Spinks et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients J. Clin. Endocrinol. Metab. 84 1999 2596-2602
14. G. Johannsson T. Rosén B.-Å. Bengtsson Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults Clin. Endocrinol. 47 1997 571-581
15. W.M. Drake J.P. Monson in: J.P. Monson (Ed.) Challenges in Growth Hormone Therapy 1999 Blackwell Science Oxford 143-159
16. H. De Boer G.J. Blok C. Popp-Snijders L. Stuurman R.C. Baxter E. Van Der Venn Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers J. Clin. Endocrinol. Metab. 81 1996 1371-1377
17. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 379-381
18. G. Johannsson R. Bjarnason M. Bramnert et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender J. Clin. Endocrinol. Metab. 81 1996 1575-1581
19. W.M. Drake D. Coyte C. Camacho-Hübner et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults J. Clin. Endocrinol. Metab. 83 1998 3913-3919
20. P. Burman A.G. Johansson Sieghn Agneta B. Vessby A. Karlsson Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women J. Clin. Endocrinol. Metab. 82 1997 550-555
21. J.P. Monson Biochemical markers of individual response to growth hormone replacement in adults Horm. Res. 55 2001 49-54
22. P. Bang R.C. Baxter W.F. Blum et al. Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd international symposium on insulin-like growth factors J. Endocrinol. 143 1994 C1-C2
23. A. Juul Serum levels of insulin-like growth factor I and its binding proteins in health and disease Growth Horm. IGF Res. 13 2003 113-170
24. A. Colao G. Cerbone R. Pivonello et al. The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency J. Clin. Endocrinol. Metab. 84 1999 1277-1282
25. A. Hilding K. Hall I.-L. Wivall-Helleryd M. Sääf A.-L. Melin M. Thorén Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years in relation to those in healthy subjects J. Clin. Endocrinol. Metab. 84 1999 2013-2019
26. D.M. Hoffman A.J. O'Sullivan R.C. Baxter K.K.Y. Ho Diagnosis of growth hormone deficiency in adults Lancet 343 1994 1064-1068
27. R.D. Murray S.J. Howell C.A. Lisset S.M. Shalet Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency Clin. Endocrinol. 52 2000 537-542
28. J.P.T. Span G.F.F.M. Pieters C.G.J. Sweep A.R.M.M. Hermus A.G.H. Smals Gender differences in insulin-like growth factors I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement J. Clin. Endocrinol. Metab. 85 2000 1121-1125
29. J.O.L. Jørgensen N. Vahl T.B. Hansen Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects Clin. Endocrinol. 48 1997 479-486
30. S.M. Pincus E.F. Gevers I.C. Robinson et al. Females secrete growth hormone with more process irregularity than males in both humans and rats Am. J. Physiol. 270 1996 E107-E115
31. G. VandenBerg J.D. Veldhuis M. Frölich F. Roelfsema An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender differences in mean GH concentrations in men and premenopausal women J. Clin. Endocrinol. Metab. 81 1996 2460-2467
32. B.-Å. Bengtsson H. Bennmarker Abs Roger et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults J. Clin. Endocrinol. Metab. 84 1999 3929-3935
33. D.M. Cook W.H. Ludlam M.B. Cook Rout of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults J. Clin. Endocrinol. Metab. 84 1999 3956-3960
34. J.J. Kelly I.A. Rajkovic A.J. O'Sullivan C. Sernia K.K. HO Effects of differential oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women Clin. Endocrinol. (Oxf) 39 1993 561-567
35. D. Goodman-Gruen E. Barret-Connor Effects of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo study J. Clin. Endocrinol. Metab. 81 1997 123-128
36. A.J. Weissberger K.Y. HO L. Lazarus Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-h growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women J. Clin. Endocrinol. Metab. 72 1991 374-381
37. J.H.Y. Janssen F. Helmerhorst M. Frölich F. Roeselfsema A Switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency J. Clin. Endocrinol. Metab. 85 1 2000 464-467
38. T. Wolthers D.M. Hoffman A.G. Nugent M.W. Duncan M. Umpleby K.K.Y. HO Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women AJP Endocrinol. Metab. 281 2001 E1191-E1196
39. L. Liu G.R. Merriam R.J. Sherins Chronic sex steroid exposure increases mean plasma growth hormone concentrations and pulse amplitude in men with isolated hypogonadotropic hypogonadism J. Clin. Endocrinol. Metab. 64 1987 651-656
40. C.J. Hobbs S.R. Plymate C.J. Rosen R.A. Adler Testosterone administration increases insulin-like growth factor-I levels in normal men J. Clin. Endocrinol. Metab. 77 1993 776-779
41. S. Fisker J.O. Jorgensen N. Vahl H. Orskov J.S. Christiansen Impact of gender and androgen status on IGF-1 levels in normal and GH-deficient adults J. Clin. Endocrinol. Metab. 141 1999 601-608